Evidence map›Paper›PMID 26538284›Full record

ArticleMolecular cancer research : MCR2016

Defining ATM-Independent Functions of the Mre11 Complex with a Novel Mouse Model.

Alessia Balestrini, Laura Nicolas, Katherine Yang-Lott, Olga A Guryanova, Ross L Levine, Craig H Bassing, Jayanta Chaudhuri, John H J Petrini

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cancer research : MCR, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Nbn-Mre11 interaction is required for tumor suppression and genomic integrity.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  5. Article
  6. Article
  7. There and Back Again: The Middle Earth of DNA Repair.Molecular cancer research : MCR · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Alessia BalestriniMolecular Biology Program, Sloan-Kettering Institute, New York, New York.
Laura NicolasImmunology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Katherine Yang-LottDepartment of Pathology and Laboratory Medicine, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Abramson Family Cancer Research Institute, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Olga A GuryanovaHuman Oncology and Pathogenesis Program, Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.
Ross L LevineHuman Oncology and Pathogenesis Program, Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.
Craig H BassingDepartment of Pathology and Laboratory Medicine, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Abramson Family Cancer Research Institute, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Jayanta ChaudhuriImmunology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
John H J PetriniMolecular Biology Program, Sloan-Kettering Institute, New York, New York. petrinij@mskcc.org.
Memorial Sloan Kettering Cancer Center · USChildren's Hospital of Philadelphia · USKettering University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
ROLES OF MRELL AND RAD50 IN THE DNA DAMAGE RESPONSER01GM056888 · NIGMS · UNIVERSITY OF WISCONSIN MADISON · PI PETRINI, JOHN HJ · 1998 to 2019
$8.6M
Mechanistic Elucidation of Class Switch Recombination and Somatic HypermutationR01AI072194 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI CHAUDHURI, JAYANTA · 2009 to 2025
$6.9M
Regulation of the DNA damage response by the Mre11 complexR37GM059413 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI PETRINI, JOHN HJ · 2012 to 2020
$5.2M
The Mre11 complex: linking recombination to checkpointsR01GM059413 · NIGMS · UNIVERSITY OF WISCONSIN MADISON · PI PETRINI, JOHN HJ · 1999 to 2011
$5.2M
The Proneural Perivascular Niche and Therapeutic ResponseU54CA163167 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI HUSE, JASON · 2011 to 2015
$4.6M
ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKSR01CA136470 · NCI · WASHINGTON UNIVERSITY · PI BASSING, CRAIG H, SLECKMAN, BARRY P · 2009 to 2013
$1.6M
Molecular Pathways in Suppression and Development of T Lineage LymphomasR01CA125195 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI BASSING, CRAIG H · 2007 to 2011
$1.6M
Biologic and therapeutic relevance of DNMT3A mutations in acute myeloid leukemiaK99CA178191 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI GURYANOVA, OLGA A · 2013 to 2014
$196k
FASEB SRC on Genetic Recombination and Genome RearrangementsR13CA162528 · NCI · FEDERATION OF AMER SOC FOR EXPER BIOLOGY · PI PETRINI, JOHN HJ · 2011 to 2011
$5k
NCI NIH HHS CA125195NCI NIH HHS CA136470NCI NIH HHS K99 CA178191NCI NIH HHS NIH/NCI 1K99CA178191NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA125195NCI NIH HHS R01 CA136470NCI NIH HHS R13 CA162528NCI NIH HHS U54 CA163167NIAID NIH HHS 1R01AI072194NIAID NIH HHS R01 AI072194NIGMS NIH HHS GM59413NIGMS NIH HHS R01 GM056888NIGMS NIH HHS R01 GM059413NIGMS NIH HHS R37 GM059413
6 · The paper itself

Abstract

unlabelledThe Mre11 complex (Mre11, Rad50, and Nbs1) occupies a central node of the DNA damage response (DDR) network and is required for ATM activation in response to DNA damage. Hypomorphic alleles of MRE11 and NBS1 confer embryonic lethality in ATM-deficient mice, indicating that the complex exerts ATM-independent functions that are essential when ATM is absent. To delineate those functions, a conditional ATM allele (ATM(flox)) was crossed to hypomorphic NBS1 mutants (Nbs1(ΔB/ΔB) mice). Nbs1(ΔB/ΔB) Atm(-/-) hematopoietic cells derived by crossing to vav(cre) were viable in vivo. Nbs1(ΔB/ΔB) Atm(-/-) (VAV) mice exhibited a pronounced defect in double-strand break repair and completely penetrant early onset lymphomagenesis. In addition to repair defects observed, fragile site instability was noted, indicating that the Mre11 complex promotes genome stability upon replication stress in vivo. The data suggest combined influences of the Mre11 complex on DNA repair, as well as the responses to DNA damage and DNA replication stress. IMPLICATIONS: A novel mouse model was developed, by combining a vav(cre)-inducible ATM knockout mouse with an NBS1 hypomorphic mutation, to analyze ATM-independent functions of the Mre11 complex in vivo. These data show that the DNA repair, rather than DDR signaling functions of the complex, is acutely required in the context of ATM deficiency to suppress genome instability and lymphomagenesis.

Indexed as

Chromosome Fragile SitesDisease Models, AnimalDNA RepairAge of OnsetAnimalsAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsDNA-Binding ProteinsDNA Breaks, Double-StrandedDNA Repair EnzymesDNA ReplicationLymphomaMiceMice, KnockoutMutationNuclear ProteinsAtaxia Telangiectasia Mutated ProteinsAtm protein, mouseCell Cycle ProteinsDNA-Binding ProteinsDNA Repair EnzymesNijmegen breakage syndrome 1 protein, mouseNuclear Proteins

Identifiers

PMID26538284
PMCPMC4755792
OpenAlexW2243118688

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.